Treatment of Lip Blisters (Herpes Labialis)
For a 32-year-old man with 3-day history of lip blisters, initiate oral antiviral therapy immediately with either valacyclovir 2g twice daily for 1 day OR famciclovir 1500mg as a single dose, as these short-course oral regimens are superior to topical therapy and can still provide benefit even at day 3 of symptoms. 1
Why Oral Antivirals Are the Treatment of Choice
The diagnosis is almost certainly herpes labialis (cold sores) caused by HSV-1 reactivation, based on the clinical presentation of vesicles/blisters on the lips 1. While the condition is self-limiting, oral antiviral therapy offers meaningful clinical benefits:
- Reduces healing time by approximately 1 day 1
- Decreases pain duration 1
- May prevent lesion progression (blocks episodes in 34.9% vs 28.1% with placebo) 2
- Reduces viral shedding 3
Specific Treatment Regimens
First-line options (FDA-approved short-course regimens):
Alternative regimens:
- Acyclovir: 400mg 5 times daily for 5 days (less convenient, requires more frequent dosing) 1
Critical Timing Considerations
Important caveat: Peak viral replication occurs in the first 24 hours after lesion onset 1. At 3 days into the outbreak, the patient is past the optimal treatment window, but oral antivirals can still provide benefit by:
- Accelerating resolution of existing lesions
- Reducing pain and discomfort
- Shortening overall episode duration 1
Treatment should be initiated immediately despite the 3-day delay, as some benefit persists even when started within 48-72 hours 3.
Why Not Topical Therapy?
Topical antivirals (acyclovir cream, penciclovir cream) provide only small clinical benefit and require frequent application (5-6 times daily for 5 days) 1. The evidence shows oral antivirals are superior to topical agents 1. Topical therapy would be a second-line option only if oral therapy is contraindicated or unavailable.
Additional Management
Symptomatic relief:
- OTC topical anesthetics for pain
- Petroleum jelly to prevent cracking 4
Prevention of future outbreaks:
- Sunscreen (SPF ≥15) to prevent UV-triggered recurrences 1, 5
- Consider chronic suppressive therapy (valacyclovir 500mg daily or acyclovir 400mg twice daily) only if patient has ≥6 episodes per year 3, 5
Safety Profile
All three oral antivirals (valacyclovir, famciclovir, acyclovir) are well-tolerated with minimal adverse events. Headache and nausea occur in <10% and <4% of patients respectively, and are mild-to-moderate 1. No serious adverse events have been reported with short-course therapy 1.
Practical Algorithm
- Confirm clinical diagnosis (grouped vesicles/blisters on lips, may have prodrome of tingling/burning) 1
- Prescribe oral antiviral immediately (valacyclovir 2g BID x1 day OR famciclovir 1500mg single dose)
- Counsel on early self-treatment for future episodes (initiate at prodrome or within first 24 hours)
- Recommend sunscreen for UV exposure
- Consider suppressive therapy only if ≥6 recurrences annually
The key message: Don't delay treatment further—start oral antivirals now despite being 3 days into the outbreak, as they remain beneficial and are far superior to topical options or no treatment.